Atlas Trials

Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease

Clinical trial NCT00100334 · COMPLETED

Trial details

NCT number
NCT00100334
Sponsor
PRAECIS Pharmaceuticals Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2004-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.